Clinical Trial Update: Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating plecanatide in children aged 6 to under 18 with irritable bowel syndrome with constipation has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Plecanatide (plecanatide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Irritable Bowel Syndrome With Constipation | Phase 2 | Status: COMPLETED | Results posted: 2025-12-31